Evidence map›Paper›PMID 23763980›Full record

ArticleThe Journal of allergy and clinical immunology2013

IL-13 receptor α2 contributes to development of experimental allergic asthma.

Weiguo Chen, Umasundari Sivaprasad, Aaron M Gibson, Mark B Ericksen, Christie M Cunningham, Stacey A Bass, Kayla G Kinker, Fred D Finkelman, Marsha Wills-Karp, Gurjit K Khurana Hershey

Open access · greenAbstract read
In one paragraph

Article in The Journal of allergy and clinical immunology, 2013. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 23 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
23citing papers in PubMed, 1 pooled it
1.9field-weighted citation impact, top 15% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

23 citing papers in PubMed, 1 synthesis or guideline pooled it, 45 citations in OpenAlex.

  1. Pooled it
  2. Article
  3. Article
  4. Article
  5. Article
  6. Review
  7. Modulation of IL-4/IL-13 cytokine signaling in the context of allergic disease.The Journal of allergy and clinical immunology · 2022
    Review
  8. Article
  9. Article
  10. Article
  11. Article
  12. Article
  13. Article
  14. Article
  15. Function of secreted phospholipase ABiochimica et biophysica acta. Molecular and cell biology of lipids · 2019
    Review
  16. Review
  17. Article
  18. Article
  19. Review
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors at 1 institution in 1 country.

Weiguo ChenDivision of Asthma Research, Cincinnati Children's Hospital Medical Center, Cincinnati, Ohio.
Umasundari Sivaprasad
Aaron M Gibson
Mark B Ericksen
Christie M Cunningham
Stacey A Bass
Kayla G Kinker
Fred D Finkelman
Marsha Wills-Karp
Gurjit K Khurana Hershey
Cincinnati Children's Hospital Medical Center · US

Funding

Unique Effects of IL-13 in Asthma: Mechanistic AnalysisP01HL076383 · NHLBI · CINCINNATI CHILDRENS HOSP MED CTR · PI ROTHENBERG, MARC E. · 2004 to 2008
$10.1M
Cincinnati Center for Excellence in Molecular HematologyP30DK090971 · NIDDK · CINCINNATI CHILDRENS HOSP MED CTR · PI ZHENG, YI · 2010 to 2015
$4.0M
Role of Il-13 Receptors in Atopic DermatitisR01AR054490 · NIAMS · CINCINNATI CHILDRENS HOSP MED CTR · PI KHURANA HERSHEY, GURJIT K. · 2007 to 2011
$1.8M
Biology of IL-13 Receptor Alpha 2R01AI058157 · NIAID · CINCINNATI CHILDRENS HOSP MED CTR · PI KHURANA HERSHEY, GURJIT K. · 2004 to 2008
$1.4M
Direct IL-4 and IL-13 effects on pulmonary smooth muscle in allergic airway diseaR01HL097360 · NHLBI · CINCINNATI CHILDRENS HOSP MED CTR · PI FINKELMAN, FRED DOUGLASS · 2009 to 2010
$951k
Biology of IL-13 receptor Alpha-2 in AsthmaR56AI084414 · NIAID · CINCINNATI CHILDRENS HOSP MED CTR · PI KHURANA HERSHEY, GURJIT K. · 2009 to 2009
$379k
NHLBI NIH HHS P01 HL076383NHLBI NIH HHS R01 HL097360NIAID NIH HHS R01 AI058157NIAID NIH HHS R56 AI084414NIAMS NIH HHS R01 AR054490NIAMS NIH HHS R01AR054490NIDDK NIH HHS P30 DK090971
6 · The paper itself

Abstract

backgroundIL-13 receptor α2 (IL-13Rα2) binds IL-13 with high affinity and modulates IL-13 responses. There are soluble and membrane forms of IL-13Rα2 generated by alternative splicing in mice, but human subjects express only the membrane form of IL-13Rα2 (memIL-13Rα2).

objectiveWe determined the role of memIL-13Rα2 in the development of allergic inflammation in mouse models of asthma.

methodsIL-13Rα2-deficient and memIL-13Rα2 lung epithelium-specific transgenic mice were challenged with house dust mite (HDM). Airway hyperresponsiveness (AHR) and inflammation were assessed based on the airway pressure-time index, bronchoalveolar lavage (BAL) cell counts, and lung histology. Mucus production was determined by means of periodic acid-Schiff staining of lung sections, Western blot analysis of chloride channel calcium activated 3 (CLCA3) expression in lung homogenates, and ELISA of Muc5ac in BAL fluid. The expression of cytokines and chemokines was determined by using RT-quantitative PCR.

resultsIn IL-13Rα2-deficient mice AHR and airway inflammation were attenuated compared with levels seen in wild-type mice after HDM challenge. Lung epithelial overexpression of memIL-13Rα2 in the IL-13Rα2-deficient mice reconstituted AHR and inflammation to levels similar to those observed in HDM-challenged wild-type mice. Mucus production was attenuated in lungs from HDM-treated IL-13Rα2-deficient mice, whereas lung epithelial overexpression of memIL-13Rα2 increased mucus production. Lung epithelial overexpression of memIL-13Rα2 had no effect on levels of the soluble form of IL-13Rα2 in serum or BAL fluid and did not affect IL-13-dependent signal transducer and activator of transcription 6 activation in the lungs.

conclusionThese data collectively support a distinct role for memIL-13Rα2 in the lung and suggest that memIL-13Rα2 might contribute to allergic inflammation.

Indexed as

AnimalsAsthmaBronchial HyperreactivityBronchoalveolar Lavage FluidCell MembraneDisease Models, AnimalFemaleHumansHypersensitivityInflammationInterleukin-13 Receptor alpha2 SubunitLungMaleMicePyroglyphidaeInterleukin-13 Receptor alpha2 SubunitAHRairway hyperresponsivenessAirway hyperresponsivenessairway inflammationAirway pressure-time indexAPTIBALBALFBronchoalveolar lavageBronchoalveolar lavage fluidChloride channel calcium activated 3CLCA3Electrophoretic mobility shift assayEMSAHDMhGHHouse dust miteHuman growth hormoneIL-13IL-13 receptorIL-13 receptor α1IL-13 receptor α2IL-13Rα1IL-13Rα2IL-4 receptor αIL-4RαlungMCPMembrane form of IL-13Rα2memIL-13Rα2Monocyte chemoattractant proteinPASPeriodic acid–SchiffqPCRQuantitative PCRRat Clara cell 10 kDarCC10Signal transducer and activator of transcription 6sIL-13Rα2Soluble form of IL-13Rα2STAT6

Identifiers

PMID23763980
PMCPMC3836839
OpenAlexW2004980323

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.